CereCura Nanotherapeutics
PrivateLast Round
Seed
Nov 14, 2025
Total Funding Raised
$1.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CereCura Nanotherapeutics operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Seed round in November 2025.
CereCura Nanotherapeutics is a biotechnology company that develops lipid nanoparticle-based RNA therapeutics to treat neurological disorders by enabling the brain to synthesize its own therapeutic proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CereCura Nanotherapeutics Comparables
Compare CereCura Nanotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurCan Therapeutics | 88% | |
| Aerska | 84% | |
| Gate2Brain | 83% |
For institutional investors. Book with your work email.
CereCura Nanotherapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CereCura Nanotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WUTIF Management Corporation | Seed |
| entrepreneurship@UBC | Seed |
| E-Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 85% MoM.
- Nov 14, 2025
$1M round led by wutif-capital
For institutional investors. Book with your work email.
CereCura Nanotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CereCura Nanotherapeutics's valuation, stock price, and market status.
Is CereCura Nanotherapeutics a public or private company?
CereCura Nanotherapeutics is a private company.
What is the current stock price of CereCura Nanotherapeutics?
CereCura Nanotherapeutics is a private company, so its shares have no public market price. Caplight tracks CereCura Nanotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CereCura Nanotherapeutics worth (valuation)?
Valuation information for CereCura Nanotherapeutics is not publicly available.
Can I buy CereCura Nanotherapeutics stock?
CereCura Nanotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CereCura Nanotherapeutics's last funding round?
CereCura Nanotherapeutics's most recent funding round was Seed on November 14, 2025.
Who are the main investors in CereCura Nanotherapeutics?
Key investors in CereCura Nanotherapeutics include WUTIF Management Corporation.
Will CereCura Nanotherapeutics IPO soon?
No public IPO plans have been announced for CereCura Nanotherapeutics.
How can I track CereCura Nanotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in CereCura Nanotherapeutics's shares on secondary markets.